Logo image of DEX.MI

DEXELANCE SPA (DEX.MI) Stock Fundamental Analysis

BIT:DEX - IT0005543480 - Common Stock

6.7 EUR
+0.1 (+1.52%)
Last: 9/5/2025, 5:27:32 PM
Fundamental Rating

5

Taking everything into account, DEX scores 5 out of 10 in our fundamental rating. DEX was compared to 33 industry peers in the Household Durables industry. DEX has an average financial health and profitability rating. DEX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

DEX had positive earnings in the past year.
DEX had a positive operating cash flow in the past year.
Of the past 5 years DEX 4 years were profitable.
In the past 5 years DEX always reported a positive cash flow from operatings.
DEX.MI Yearly Net Income VS EBIT VS OCF VS FCFDEX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

DEX's Return On Assets of 4.04% is fine compared to the rest of the industry. DEX outperforms 65.71% of its industry peers.
With a decent Return On Equity value of 10.92%, DEX is doing good in the industry, outperforming 62.86% of the companies in the same industry.
DEX has a Return On Invested Capital of 7.68%. This is in the better half of the industry: DEX outperforms 68.57% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DEX is below the industry average of 10.58%.
Industry RankSector Rank
ROA 4.04%
ROE 10.92%
ROIC 7.68%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
DEX.MI Yearly ROA, ROE, ROICDEX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

Looking at the Profit Margin, with a value of 3.83%, DEX is in line with its industry, outperforming 60.00% of the companies in the same industry.
In the last couple of years the Profit Margin of DEX has declined.
DEX has a Operating Margin (7.13%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of DEX has declined.
DEX has a Gross Margin of 39.27%. This is comparable to the rest of the industry: DEX outperforms 57.14% of its industry peers.
DEX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.13%
PM (TTM) 3.83%
GM 39.27%
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
DEX.MI Yearly Profit, Operating, Gross MarginsDEX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

DEX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
DEX has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, DEX has an improved debt to assets ratio.
DEX.MI Yearly Shares OutstandingDEX.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
DEX.MI Yearly Total Debt VS Total AssetsDEX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 1.96 indicates that DEX is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.96, DEX is in line with its industry, outperforming 45.71% of the companies in the same industry.
DEX has a debt to FCF ratio of 4.55. This is a neutral value as DEX would need 4.55 years to pay back of all of its debts.
DEX has a better Debt to FCF ratio (4.55) than 71.43% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that DEX is not too dependend on debt financing.
The Debt to Equity ratio of DEX (0.38) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.55
Altman-Z 1.96
ROIC/WACC1.19
WACC6.45%
DEX.MI Yearly LT Debt VS Equity VS FCFDEX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

DEX has a Current Ratio of 1.12. This is a normal value and indicates that DEX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DEX (1.12) is worse than 74.29% of its industry peers.
DEX has a Quick Ratio of 1.12. This is a bad value and indicates that DEX is not financially healthy enough and could expect problems in meeting its short term obligations.
DEX has a Quick ratio (0.81) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.81
DEX.MI Yearly Current Assets VS Current LiabilitesDEX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

DEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -44.20%.
The Earnings Per Share has been growing by 16.38% on average over the past years. This is quite good.
Looking at the last year, DEX shows a quite strong growth in Revenue. The Revenue has grown by 12.85% in the last year.
Measured over the past years, DEX shows a very strong growth in Revenue. The Revenue has been growing by 31.04% on average per year.
EPS 1Y (TTM)-44.2%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-954.7%
Revenue 1Y (TTM)12.85%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%-0.87%

3.2 Future

The Earnings Per Share is expected to grow by 1.65% on average over the next years.
The Revenue is expected to grow by 2.91% on average over the next years.
EPS Next Y-13.03%
EPS Next 2Y-3.26%
EPS Next 3Y1.65%
EPS Next 5YN/A
Revenue Next Year0.79%
Revenue Next 2Y2.23%
Revenue Next 3Y2.91%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DEX.MI Yearly Revenue VS EstimatesDEX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
DEX.MI Yearly EPS VS EstimatesDEX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.15, which indicates a very decent valuation of DEX.
Based on the Price/Earnings ratio, DEX is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of DEX to the average of the S&P500 Index (27.06), we can say DEX is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.37, the valuation of DEX can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DEX indicates a somewhat cheap valuation: DEX is cheaper than 77.14% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.69. DEX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.15
Fwd PE 8.37
DEX.MI Price Earnings VS Forward Price EarningsDEX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DEX is valued cheaply inside the industry as 88.57% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, DEX is valued a bit cheaper than the industry average as 74.29% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.85
EV/EBITDA 3.73
DEX.MI Per share dataDEX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.26%
EPS Next 3Y1.65%

More info and screens

0

5. Dividend

5.1 Amount

DEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DEXELANCE SPA

BIT:DEX (9/5/2025, 5:27:32 PM)

6.7

+0.1 (+1.52%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners14.93%
Inst Owner ChangeN/A
Ins Owners3.17%
Ins Owner ChangeN/A
Market Cap180.43M
Analysts88.57
Price Target11.49 (71.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.59%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-25.7%
EPS NY rev (3m)-25.7%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.99%
Valuation
Industry RankSector Rank
PE 10.15
Fwd PE 8.37
P/S 0.38
P/FCF 8.85
P/OCF 7.13
P/B 1.08
P/tB N/A
EV/EBITDA 3.73
EPS(TTM)0.66
EY9.85%
EPS(NY)0.8
Fwd EY11.95%
FCF(TTM)0.76
FCFY11.3%
OCF(TTM)0.94
OCFY14.02%
SpS17.72
BVpS6.21
TBVpS-2.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.04%
ROE 10.92%
ROCE 10.57%
ROIC 7.68%
ROICexc 8.82%
ROICexgc 52.73%
OM 7.13%
PM (TTM) 3.83%
GM 39.27%
FCFM 4.27%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
ROICexc(3y)10.38%
ROICexc(5y)9.17%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.86%
ROCE(5y)9.5%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-10.93%
ROICexc growth 5YN/A
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
F-Score7
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.55
Debt/EBITDA 1.11
Cap/Depr 21.25%
Cap/Sales 1.03%
Interest Coverage 250
Cash Conversion 44.3%
Profit Quality 111.6%
Current Ratio 1.12
Quick Ratio 0.81
Altman-Z 1.96
F-Score7
WACC6.45%
ROIC/WACC1.19
Cap/Depr(3y)32.47%
Cap/Depr(5y)34.25%
Cap/Sales(3y)1.91%
Cap/Sales(5y)2.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.2%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-954.7%
EPS Next Y-13.03%
EPS Next 2Y-3.26%
EPS Next 3Y1.65%
EPS Next 5YN/A
Revenue 1Y (TTM)12.85%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%-0.87%
Revenue Next Year0.79%
Revenue Next 2Y2.23%
Revenue Next 3Y2.91%
Revenue Next 5YN/A
EBIT growth 1Y-22.63%
EBIT growth 3Y25.09%
EBIT growth 5YN/A
EBIT Next Year47.8%
EBIT Next 3Y13.65%
EBIT Next 5YN/A
FCF growth 1Y157.29%
FCF growth 3Y8.28%
FCF growth 5YN/A
OCF growth 1Y97.69%
OCF growth 3Y11.3%
OCF growth 5YN/A